Skip to main content

Inhibrx, Inc. (INBX)

NASDAQ: INBX · IEX Real-Time Price · USD
39.71 -0.29 (-0.73%)
Oct 15, 2021 4:00 PM EDT - Market closed

Total Valuation

Inhibrx has a market cap or net worth of $1.50 billion. The enterprise value is $1.46 billion.

Market Cap1.50B
Enterprise Value1.46B

Important Dates

The next estimated earnings date is Nov 8, 2021, which is a Monday.

Estimated Earnings DateNov 8, 2021
Ex-Dividend Daten/a

Share Statistics

Inhibrx has 37.82 million shares outstanding. The number of shares has increased by 108.35% in one year.

Shares Outstanding37.82M
Shares Change (YoY)+108.35%
Shares Change (QoQ)+0.23%
Owned by Insiders (%)39.98%
Owned by Institutions (%)55.38%
Float17.44M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio143.03
PB Ratio33.95
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.

EV / Earningsn/a
EV / Sales138.41
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 6.06, with a Debt / Equity ratio of 1.74.

Current Ratio6.06
Quick Ratio5.83
Debt / Equity1.74
Debt / EBITDA-1.12
Debt / FCF-1.03

Financial Efficiency

Return on Equity (ROE)-114.90%
Return on Assets (ROA)-56.50%
Return on Capital (ROIC)-238.10%
Revenue Per Employee$125,238
Profits Per Employee-$930,298
Employee Count84
Asset Turnover0.08
Inventory Turnovern/a

Taxes

In the past 12 months, Inhibrx has paid $5,000 in taxes.

Income Tax5,000
Effective Tax Rate-0.01%

Stock Price Statistics

The stock price has increased by +121.85% in the last 52 weeks.

Beta (1Y)n/a
52-Week Price Change+121.85%
50-Day Moving Average33.18
200-Day Moving Average25.98
Average Volume (30 Days)276,195

Short Selling Information

Short Interest856,535
Short % of Shares Out2.26%
Short % of Float4.91%
Short Ratio (days to cover)5.82

Income Statement

In the last 12 months, Inhibrx had revenue of $10.52 million and -$78.15 million in losses. Earnings per share was -$2.23.

Revenue10.52M
Gross Profit10.52M
Operating Income-71.02M
Pretax Income-78.14M
Net Income-78.15M
EBITDA-68.99M
EBIT-71.52M
Earnings Per Share (EPS)-$2.23
Full Income Statement

Balance Sheet

The company has $125.73 million in cash and $77.15 million in debt, giving a net cash position of $48.58 million or $1.28 per share.

Cash & Cash Equivalents125.73M
Total Debt77.15M
Net Cash48.58M
Net Cash Per Share$1.28
Book Value44.32M
Book Value Per Share1.17
Working Capital109.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$73.30 million and capital expenditures -$1.28 million, giving a free cash flow of -$74.58 million.

Operating Cash Flow-73.30M
Capital Expenditures-1.28M
Free Cash Flow-74.58M
FCF Per Share-$1.97
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -675.13% and -742.82%.

Gross Margin100.00%
Operating Margin-675.13%
Pretax Margin-742.78%
Profit Margin-742.82%
EBITDA Margin-655.78%
EBIT Margin-679.86%
FCF Margin-708.96%

Dividends & Yields

Inhibrx does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-5.19%
FCF Yield-4.96%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a